Wooree Bio Co.Ltd (082850) — Cash Flow Quality Index
Wooree Bio Co.Ltd (082850) has a Cash Flow Quality Index of -7.32x as of September 2025. Operating cash flow of ₩-18.11 Billion is below net income of ₩2.48 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore Wooree Bio Co.Ltd (082850) long-term investment share to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Wooree Bio Co.Ltd Cash Flow Quality Index (2008–2024)
Historical Cash Flow Quality Index for Wooree Bio Co.Ltd across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible net worth ratio of Wooree Bio Co.Ltd to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Wooree Bio Co.Ltd (2008–2024)
Year-by-year earnings quality comparison for Wooree Bio Co.Ltd. For live market cap and the full company financial profile, see market value of Wooree Bio Co.Ltd.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 4.41x | ₩36.24 Billion | ₩8.23 Billion | ▲ +214.8% |
| 2023 | 1.40x | ₩26.51 Billion | ₩18.95 Billion | ▼ -29.6% |
| 2022 | 1.99x | ₩43.35 Billion | ₩21.82 Billion | ▲ +31.2% |
| 2021 | 1.51x | ₩50.21 Billion | ₩33.16 Billion | ▼ -63.3% |
| 2020 | 4.12x | ₩69.43 Billion | ₩16.84 Billion | ▼ -71.6% |
| 2019 | 14.52x | ₩65.80 Billion | ₩4.53 Billion | ▲ +1085.8% |
| 2011 | 1.22x | ₩8.36 Billion | ₩6.83 Billion | ▼ -27.2% |
| 2010 | 1.68x | ₩17.33 Billion | ₩10.30 Billion | ▲ +17.5% |
| 2009 | 1.43x | ₩46.60 Billion | ₩32.53 Billion | ▼ -56.6% |
| 2008 | 3.30x | ₩69.27 Billion | ₩20.98 Billion | — |